Rosangela Munhoz Montenegro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rosangela Munhoz Montenegro has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alice Beatriz Mombach Pinheiro Machado
Hospital de Clínicas de Porto Alegre, Brazil
1 shared publication - Aline Lima Nogare
Post-Graduate Medical Sciences Program, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication Denise Silva Menezes
Hospital de Clínicas de Porto Alegre, Brazil
1 shared publication- Fernanda De-Paris
Hospital de Clínicas de Porto Alegre, Brazil
1 shared publication - Francisco Veríssimo Veronese
Laboratory of Molecular Biology Applied to Nephrology, Experimental Research Center, Hospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, Brazil
1 shared publication - Jose Alberto Pedroso
Renal Transplant Unit, Organ Transplant Ph.D. Program, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 39 (1) , 46-54
Evaluation of diagnostic tests for cytomegalovirus active infection in renal transplant recipients
Our data demonstrate that both methods are suitable and have almost equivalent accuracy for the detection of post-transplant cytomegalovirus replication. The choice for either test must take in consideration the demand, execution capability and cost-effectiveness at each institution.
- 1 January 2017
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 39 (1) , 46-54
Open AccessEvaluation of diagnostic tests for cytomegalovirus active infection in renal transplant recipients
Our data demonstrate that both methods are suitable and have almost equivalent accuracy for the detection of post-transplant cytomegalovirus replication. The choice for either test must take in consideration the demand, execution capability and cost-effectiveness at each institution.
- Open Access
- 13 February 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 19
Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy
Kidney injury molecule-1 (KIM-1) is expressed in tubular epithelial cells after injury and may have a role in the development of renal graft fibrosis. In this study we evaluated the molecular and protein expressions of KIM-1 in dysfunctional allografts and also mRNA KIM-1 expression in urine as potential biomarkers of graft fibrosis. Protein and mRNA levels in renal tissue and urinary sediment cells of 69 kidney transplant recipients that undertook for-cause graft biopsies were evaluated by immunohistochemistry and real-time polymerase chain reaction. The histopathology was classified according to the 2007 Banff schema. KIM-1 protein expression was increased in biopsies with interstitial fibrosis and tubular atrophy (IF/TA) compared with biopsies showing acute calcineurin inhibitor nephrotoxicity (CIN) (P <0.05). Kidney tissue KIM-1 mRNA signaling (in) was increased in biopsies with IF/TA compared with all other groups (P <0.05). In the urine cells KIM-1 mRNA was also increased in patients with IF/TA compared with patients with acute CIN (P <0.05). Significant correlations were found between KIM-1 protein and mRNA levels in tissue, between mRNA expressions in tissue and urine and between protein tissue expression and gene expression in the urine. KIM-1 seems to be a marker of kidney graft fibrosis. Urinary KIM-1 mRNA may become a useful non-invasive biomarker of the injuries that can trigger intra-graft fibrotic processes, such as interstitial fibrosis and tubular atrophy.
- 13 February 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 19
Open AccessKidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy
Kidney injury molecule-1 (KIM-1) is expressed in tubular epithelial cells after injury and may have a role in the development of renal graft fibrosis. In this study we evaluated the molecular and protein expressions of KIM-1 in dysfunctional allografts and also mRNA KIM-1 expression in urine as potential biomarkers of graft fibrosis. Protein and mRNA levels in renal tissue and urinary sediment cells of 69 kidney transplant recipients that undertook for-cause graft biopsies were evaluated by immunohistochemistry and real-time polymerase chain reaction. The histopathology was classified according to the 2007 Banff schema. KIM-1 protein expression was increased in biopsies with interstitial fibrosis and tubular atrophy (IF/TA) compared with biopsies showing acute calcineurin inhibitor nephrotoxicity (CIN) (P <0.05). Kidney tissue KIM-1 mRNA signaling (in) was increased in biopsies with IF/TA compared with all other groups (P <0.05). In the urine cells KIM-1 mRNA was also increased in patients with IF/TA compared with patients with acute CIN (P <0.05). Significant correlations were found between KIM-1 protein and mRNA levels in tissue, between mRNA expressions in tissue and urine and between protein tissue expression and gene expression in the urine. KIM-1 seems to be a marker of kidney graft fibrosis. Urinary KIM-1 mRNA may become a useful non-invasive biomarker of the injuries that can trigger intra-graft fibrotic processes, such as interstitial fibrosis and tubular atrophy.